Research analysts at HC Wainwright cut their Q1 2025 earnings estimates for Axsome Therapeutics in a research report issued ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price increased by equities research analysts at HC ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

周三 - Needham分析师将Axsome Therapeutics (NASDAQ: AXSM )的目标股价从133.00美元上调至153.00美元，同时维持买入评级。该股今年以来表现强劲，涨幅超过51%，目前交易价格接近52周高点134.19美元。此次调整是在Axsome发布2024年第四季度财报后做出的，这份财报被描述为平淡无奇，特别是考虑到公司此前已在1月份的J.P.

Q4 2024 Earnings Call Transcript February 18, 2025 Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

英为财情Investing.com - Axsome Therapeutics (NASDAQ: AXSM )星期二发布了第四季度的财报，数据显示，公司营收逊于分析师的预期，每股收益低于分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-1.54，总营收为$117.32M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$117.69M，每股收益为$-0 ...

Highlights,Several major investment firms have adjusted their stakes in Axsome Therapeutics, reflecting evolving market ...

Highlights,Multiple financial firms have provided positive ratings for Axsome Therapeutics, reflecting confidence in the ...

Axsome Therapeutics, Inc.'s' stock surges 30% amid key catalysts. Learn why it's now rated a Buy wih upcoming data opportunities. Click for my AXSM update.

Shares of Axsome Therapeutics (NASDAQ: AXSM) are up on Tuesday. The jump comes as the S&P 500 (SNPINDEX: ^GSPC) lost 0.3% and ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM) signed a settlement agreement with Teva Pharmaceuticals Inc (NYSE:TEVA). The ...